Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Status:
Completed
Trial end date:
2016-06-22
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to evaluate, how long an antipsychotic relapse-prevention
should be continued and to which time a patient with schizophrenia is protected enough, so
that a withdrawal or reduction of the medication seems appropriate. Relapse is defined as
primary outcome.